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Prediction of glomerular filtration rate from serum creatinine
concentration in advanced chronic renal failure
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Prediction of glomerular ifitration rate from serum creatinine concen-
tration in advanced chronic renal failure. In 85 patients with established
chronic renal failure, as manifested by serum creatinine concentration
([Cr]) >0.177 mrs (> 2 mg/dl), urinary clearance of SSmTcDTPA (GFR)
and [Cr] were determined one to four times and averaged. GFR was
expressed per 3 m2 of height2 rather than in terms of 1.73 m2 of surface
area because weight changes but height does not. GFR in these patients
averaged 13 mllminl3 m2 (range 2 to 37). The following equations were
derived for predicting GFR from [Cr] (mM), age (years) and weight
(kg): males, GFR = 7.57 [Cr] — 0.103 age + 0.096 weight — 6.66;
females, GFR = 6.05 [Cr]' — 0.08 age + 0.08 weight — 4.81. These
equations predict GFR in this series with a root mean square error of 3.0
mI/mm and account for 89% of the observed variation in GFR. They are
applicable only to patients with [Cr] > 0.177 mt (2 mg/dl). More precise
estimates can be obtained by including a value for 24-hour urinary urea
N, as a measure of protein intake. Less precise but simpler estimates
can be obtained from [Cri alone: males, GFR = 7.58 [Cr] — 4.29;
females, GFR = 6.11 [Cr]' — 3.8. Expressing [Cr] in mg/dl, the latter
equations become: males, GFR = 86 [Cr]' — 4.29; females, GFR = 69[Cr] — 3.8.
The severity of chronic renal failure has traditionally been
estimated as creatinine clearance, expressed in relation to
normal values for the patient's gender, age and surface area.
Creatinine clearance is either measured from two-hour or
24-hour urine collection, or estimated from serum creatinine
concentration ([Cr]) using, for example, the formulas proposed
by Cockcroft and Gault [1].
However, there are problems with estimating severity in this
way, particularly in more advanced renal failure. First, the
Cockcroft-Gault formulas were derived from hospitalized per-
sons of whom the majority had normal renal function. In severe
chronic renal failure, creatinine excretion may fall by more than
50% [2], owing to creatinine degradation in the gut [3]. Further-
more, such patients are often consuming diets low in protein
(and thus in creatine). Second, creatinine clearance overesti-
mates glomerular filtration rate (GFR) by a large and variable
amount and this discrepancy increases as GFR falls [4—15].
Ingestion of a large dose of cimetidine reduces the discrepancy
[16], but its routine use for this purpose is questionable [17].
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Measurement of GFR is as yet not widely available, and is
relatively expensive. It was therefore of interest to determine
whether GFR could be estimated from [Cr], gender, age, and a
measure of body size such as height, weight, or surface area.
As shown herein, GFR can be estimated with reasonable
precision in this way.
Methods
Eighty-five patients with chronic renal failure were studied
(54 males and 31 females) varying in age from 23 to 79 years.
Diagnoses were: chronic glomerulonephritis 24, diabetic ne-
phropathy 17, interstitial nephritis 13, polycystic kidney disease
11, arteriolar nephrosclerosis 13, others 7. Because we were
primarily interested in predicting GFR in severe chronic renal
failure, the analysis was confined to patients with [Cr] > 0.177
mM (2 mg/dl). Mean GFR was 13 mllmin. Seventy-five of the 85
patients were prescribed a low-protein, low-phosphorus diet
(the others declined). However, protein intake per kg estimated
from 24-hour urinary urea N (UNA) as 6.25 (UNA/weight +
0.031) [18], varied widely (0.3 to 1.0 glkg), indicating variable
compliance.
GFR was determined as follows: Technetium-99m diethylen-
etriaminepentaacetic acid (mTcDTPA) was used immediately
after preparation. Radiochemical purity was verified by thin
layer chromatography. One hundred microCuries were injected
i.v. following oral water loading (1 liter). After one hour, the
patient voided. Then three spontaneously voided urine collec-
tions of 30 to 45 minutes were obtained. Venous blood samples
were obtained before and after each urine sample. Clearance
was calculated for each period as urine activity times urine flow
divided by average plasma activity. Three clearances were then
averaged.
Previous work has established that urinary clearance of
99mTcDTPA is closely correlated with inulin clearance in
patients with chronic renal failure [4, 19], being on the average
2.5 mllmin greater [19].
In five patients, a single determination of GFR was made. In
the remaining 80 patients, three to four determinations were
made (monthly or bimonthly). A few GFR's were excluded
because of inadequate urine flow, based on criteria described
elsewhere [201. [Cr] was determined by the Clinical Chemistry
Laboratory, using automated methods, each time GFR was
determined. The alkaline picrate reaction was used, which
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Table 1. Coefficients of regression equations and errors
r.m.s .e.
mI/min/
Eq. no. Gender and (no. of patients) a b c d e 3 m2 of ht2 r2
(1) GFR x 3/Ht2 = a + b [Cr] + c age + d wt
Females (31) — 4.81
3.78
+ 6.05
0.50
— 0.080
0.044
+ 0.080
0.044
3.42 0.85
Males (54) — 6.66
2.69
+ 7.57
0.36
— 0.103
0.026
+ 0.096
0.027
2.94 0.90
(2) GFRx 3/Ht2=a+b[Cr] +cage+ dwt
+ e UNA
Females (31) — 5.80
3.59
+ 5.89
0.48
— 0.082
0.041
÷ 0.053
0.045
+ 0.611
0.291
3.22 0.87
GFR x 3/Ht2 = b [Cr] + c age + d wt
+ e UNA
Males (53) — 7.16
2.35
+ 6.69
0.38
— 0.094
0.023
+ 0.064
0.025
+ 0.720
0.171
2.56 0.93
(3) GFR x 3/Ht2 = a + b [Cr]
Females (31) — 3.80
1.68
+ 6.11
0.53
3.64 0.82
Males (54) — 4.29
1.14
+ 7.58
0.45
3.64 0.84
Abbreviations are: r.m.s.e., root mean square error; r2, square of correlation coefficient; UNA, urinary urea N g/day.
includes non-creatinine chromogens. Values of GFR and [Cr]
were averaged to yield single values for each patient.
In all but one patient, 24-hour urine samples were collected
under refrigeration and analyzed for urea N by automated
methods.
"Ideal body weight" is approximately proportional to
height2. Metabolically active body mass is more closely related
to ideal body weight than actual body weight (fat being rela-
tively inactive metabolically). Furthermore, weight may
change, but height does not (except for a slight decrease in old
age). Changes in surface area lead to changes in GFR/1 .73 m2 of
surface area, when GFR in mllmin is constant. Thus use of
height2 as a referent rather than surface area obviates the need
to recalculate surface area whenever weight changes. Further-
more, loss of a substantial amount of body weight may lead to
a statistically significant progressive rise in GFRJ1 .73 m, even
when GFR is in fact constant [211. Since height2 averages
approximately 3 m in adults, we express GFR as ml/minl3 m2
of height2.
GFR x 3/Ht2 (mi/mm per 3 m2 of height2) as the dependent
variable was examined as a linear function of [Cr]' (mM1),
age (years), and weight (kg), separately for males and females,
according to the following model:
GFR x 3/Ht2 = a + b [Cr]' + c (age) + d (weight)
Multiple linear regression was used to estimate each of the
parameters a through d. Measured values for 24-hour urinary
urea N (UNA) in glday were included in a second analysis.
[Cr]1 alone was employed in a third analysis.
Results
In Table 1 are shown the parameters estimated from the data.
For all 85 patients, the correlation between observed GFR and
GFR predicted from gender, [Cr], age and weight, as shown in
Figure 1, is r = 0.94. The difference between predicted GFR
and observed GFR averages zero with a standard deviation of
3.0 mllmin/3 m2 of Ht2.
When a single value of [Cr]' (the next to last one in each
patient) was used to predict the simultaneous GFR, correlation
coefficients were similar: males, r2 = 0.90; females, r2 = 0.86.
The coefficients of variations of repeated measures of GFR
and [Cr] within patients averaged 9.7% and 7.9%, respec-
tively. The former C.V. is lower than previously reported [19].
As expected, creatinine clearance estimated from the formula
of Cockcroft and Gault [1] (using the same average [Cr] value in
each patient) usually overestimates GFR in these patients (Fig.
2), and has more scatter (r2 = 0.83). The difference between
measured GFR and estimated clearance averaged 5.9 4.4
ml/min, indicating greater percentage secretion of creatinine at
lower clearances.
In a second analysis, UNA was included as an independent
variable (Table 1). The positive coefficient for UNA reflects the
fact that individuals consuming greater quantities of protein
(and therefore creatine) are likely to have a higher serum
creatinine concentration at any given value of GFR. This
additional regressor improved the fit significantly, reducing the
overall standard deviation of prediction error to 2.65 mllmin/3
m2 of Ht2.
In the third analysis, GFR was estimated from [Cr] alone. In
both males and females, root mean square error is 3.64 ml/min/3
2 of Ht2. Overall, r2 = 0.83.
Discussion
Many authors have reported both GFR results and [Cr]
values in patients with chronic renal failure [4, 6—11, 13—15],
usually less severe than our patients. However, it appears that
there has been no previous attempt to interrelate these quanti-
ties by regression techniques. Additional observations may lead
to refinement in the coefficients of these equations. However, it
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is already clear that a relatively precise estimate of GFR can be
obtained.
Fig. 1. GFR predicted from serum creatinine,
height, weight, age and gender as a function
of DTPA GFR in 85 patients with advanced
chronic renal failure. The line of identity is
shown. r = 0.94. Regression line for males
shown as dashed line; for females as dotted
Fig. 2. Creatinine clearance as predicted by
Cockcroft and Gault's equations [ii from
serum creatinine, weight, age and gender as a40 function of DTPA GFR in the same patients
as in Figure 1. The line of identity is shown.
Regression lines as in Figure 1.
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This is surprising, because the rate of change of [Cr]
correlates poorly with rate of change of GFR [22]. Use of the
above equations in the patients in our previously reported study
[22] of progression verifies that the discrepancy between true
GFR and GFR estimated from [Cr]1 drifts from positive to
negative or from negative to positive with time in individual
patients. In fact, the principal source of error in these equations
(in subjects on restricted protein intake) may be variations
between patients in the tubular secretion of creatinine. This
time-dependent change in individual patients was the cause of
the previously noted discrepancies between progression rates
estimated from d[Cr] — '/dt and rates estimated as dGFRJdt.
Clearly, dietary protein restriction has influenced the derived
coefficients. Median protein intake, estimated as above, was
0.67 g/kg. Thus, about half of our patients were in fact consum-
ing protein-restricted diets. At these levels of GFR, all patients
should be on protein-restricted diets in order to reduce uremic
toxicity. Indeed, many such patients spontaneously reduce
their intake of protein even if not instructed to do so. Therefore,
these equations derived, for the most part, from protein-
restricted patients may be more useful in severe renal failure
than would equations derived from patients with severe renal
insufficiency who are consuming normal amounts of protein. On
the other hand, the second analysis, including a value for UNA,
is more precise, but it requires an additional measurement.
As Shemesh et al [4] have noted, [Cr] is within normal limits
in nearly half of patients whose GFR lies between 40 and 80
mllmin. In this group, renal insufficiency can be reliably dé-
tected only by measuring GFR. Since our equations were
derived from observations in patients with advanced chronic
renal failure, they should not be used to estimate GFR when
[Cr] is only slightly elevated or is within normal limits.
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